National Cancer Center Hospital:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Cancer Center Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9392
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis and treatments by utilizing advanced screening and examination protocols with high-tech systems and equipment. It offers services in the areas of thoracic surgery, breast surgery, palliative care, chemotherapy, neurosurgery, ophthalmic oncology, head and neck oncology, endoscopic treatment and radiotherapy, among others. The hospital also provides consultation and examinations services by advanced computer system in the clinics. NCC is headquartered in Tokyo, Japan.

National Cancer Center Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14
Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15
Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16
VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18
National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19
Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20
Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21
National Cancer Center Hospital – Key Competitors 22
National Cancer Center Hospital – Key Employees 23
National Cancer Center Hospital – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jun 01, 2018: NCC Establishes Center for Cancer Genomics and Advanced Therapeutics (C-CAT) to Aggregate and Manage Information on Cancer Genomic Medicine and Promote Its Use 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Key Facts 2
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Center Hospital, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KAN Research Institute Enters into Development Agreement with Six Research Organizations 12
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14
Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15
Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16
VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18
National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19
Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20
Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21
National Cancer Center Hospital, Key Competitors 22
National Cancer Center Hospital, Key Employees 23
National Cancer Center Hospital, Other Locations 24
National Cancer Center Hospital, Subsidiaries 24

List of Figures
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[National Cancer Center Hospital:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Health GmbH (Molecular Health) is a biomedical company that designs, develops, manufactures and commercializes software systems which performs integrated analysis of clinical and genomic patient data to support treatment decisions and provide related services. The company offers Mo …
  • CSC Steel Holdings Berhad:企業の戦略・SWOT・財務情報
    CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Febo Beheer BV:企業の戦略・SWOT・財務情報
    Febo Beheer BV - Strategy, SWOT and Corporate Finance Report Summary Febo Beheer BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Proximus plc:企業の戦略・SWOT・財務分析
    Proximus plc - Strategy, SWOT and Corporate Finance Report Summary Proximus plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • INC Research LLC-製薬・医療分野:企業M&A・提携分析
    Summary INC Research LLC (INC Research), a subsidiary of INC Research Holdings Inc is a healthcare services provider that offers contract research services. The organization provides phase I to IV clinical development services. Its services include study start-up, INC pressure test, INC patient elig …
  • SHL TeleMedicine Ltd (SHLTN):医療機器:M&Aディール及び事業提携情報
    Summary SHL TeleMedicine Ltd (SHL) is a provider of advanced personal telemedicine systems and solutions. The company's staff monitors the health of patients to minimize the need for emergency intervention and hospitalization. Its product portfolio includes ECG transmitters, oximeter, and hand held …
  • Mindteck (India) Limited:戦略・SWOT・企業財務分析
    Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Goteborg Energi AB:発電所・企業SWOT分析
    Goteborg Energi AB - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務分析
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • ADOBE Inc (ADBE):企業の財務・戦略的SWOT分析
    ADOBE Inc (ADBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Andhra Pradesh Power Generation Corp Ltd:企業の戦略的SWOT分析
    Andhra Pradesh Power Generation Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Continental AG:企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Mediware Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • CNX Resources Corp (CNX):石油・ガス:M&Aディール及び事業提携情報
    Summary CNX Resources Corporation (CNX Resources), formerly CONSOL Energy Inc., is an independent oil and natural gas company. It carries out the exploration, development, production, gathering, processing and acquisition of natural gas properties in the Appalachian Basin. The company has interests …
  • Diazyme Laboratories Inc:製品パイプライン分析
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a developer of diagnostic reagents. The company’s products include vitamin D assays, vitamin D assay for clinical chemistry analyzers, adenosine deaminase assay, cardiac troponin I assay, creatinine assay, D-dimer assay, direct enzymatic HbA …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nordex SE (NDX1)-エネルギー分野:企業M&A・提携分析
    Summary Nordex SE (Nordex) is a manufacturer of wind turbines. Along with its subsidiaries, the company conducts the development, production, servicing and marketing of wind power systems. The service portfolio related to technical planning of wind farm systems ranges from the identification of suit …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆